Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy of melanoma: Present options and future promises
Anand Rotte, Madhuri Bhandaru, Youwen Zhou, et al.
Cancer and Metastasis Reviews (2015) Vol. 34, Iss. 1, pp. 115-128
Closed Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Anand Rotte
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 826
Cytokines in the Treatment of Cancer
Kevin C. Conlon, Miloš D. Miljković, Thomas A. Waldmann
Journal of Interferon & Cytokine Research (2018) Vol. 39, Iss. 1, pp. 6-21
Open Access | Times Cited: 413
Mechanistic overview of immune checkpoints to support the rational design of their combinations in cancer immunotherapy
Anand Rotte, Jiangtao Jin, Vincent Lemaire
Annals of Oncology (2017) Vol. 29, Iss. 1, pp. 71-83
Open Access | Times Cited: 319
Prognostic significance of PD-L1 and PD-L2 in breast cancer
Mauricio Z. Baptista, Luı́s Otávio Sarian, Sophie Derchain, et al.
Human Pathology (2015) Vol. 47, Iss. 1, pp. 78-84
Closed Access | Times Cited: 226
Precision Cancer Nanotherapy: Evolving Role of Multifunctional Nanoparticles for Cancer Active Targeting
Anas Ahmad, Farheen Khan, Rakesh Kumar Mishra, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 23, pp. 10475-10496
Closed Access | Times Cited: 154
BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers
Giorgia Castellani, Mariachiara Buccarelli, Maria Beatrice Arasi, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4026-4026
Open Access | Times Cited: 60
Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy
Samantha Bowyer, Prashanth Prithviraj, Paul Lorigan, et al.
British Journal of Cancer (2016) Vol. 114, Iss. 10, pp. 1084-1089
Open Access | Times Cited: 125
Comparative Aspects of Canine Melanoma
Adriana Tomoko Nishiya, Cristina de Oliveira Massoco, Cláudia Ronca Felizzola, et al.
Veterinary Sciences (2016) Vol. 3, Iss. 1, pp. 7-7
Open Access | Times Cited: 124
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy
Jared E. Lopes, Jan L. Fisher, Heather Flick, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000673-e000673
Open Access | Times Cited: 115
Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development
Anand Rotte, Srikumar Sahasranaman, Nageshwar Budha
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1277-1277
Open Access | Times Cited: 58
Malignant melanoma: diagnosis, treatment and cancer stem cells
Zuzana Kozovská, Veronika Gabrisova, Lucia Kučerová
Neoplasma (2016) Vol. 63, Iss. 04, pp. 510-517
Open Access | Times Cited: 75
Monoclonal Antibodies for the Treatment of Melanoma: Present and Future Strategies
Madhuri Bhandaru, Anand Rotte
Methods in molecular biology (2018), pp. 83-108
Closed Access | Times Cited: 65
Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility
Monica Marzagalli, Marina Montagnani Marelli, Lavinia Casati, et al.
Frontiers in Endocrinology (2016) Vol. 7
Open Access | Times Cited: 63
Combination Strategies to Augment Immune Check Point Inhibitors Efficacy - Implications for Translational Research
Hrishi Varayathu, Vinu Sarathy, Beulah Elsa Thomas, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 55
Improving cancer immunotherapy by targeting the STATe of MDSCs
Nienke de Haas, Coco de Koning, Lisanne M. Spilgies, et al.
OncoImmunology (2016) Vol. 5, Iss. 7, pp. e1196312-e1196312
Open Access | Times Cited: 56
Interleukin-2: Old and New Approaches to Enhance Immune-Therapeutic Efficacy
Pooja Dhupkar, Nancy Gordon
Advances in experimental medicine and biology (2017), pp. 33-51
Closed Access | Times Cited: 56
Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits
Jiaojiao Hao, Wenhua Fan, Yizhuo Li, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 47
The efficacy and safety of combined immune checkpoint inhibitors (nivolumab plus ipilimumab): a systematic review and meta-analysis
Jingjie Chen, Shengnan Li, Qigu Yao, et al.
World Journal of Surgical Oncology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 40
Precision medicine driven by cancer systems biology
Fabian V. Filipp
Cancer and Metastasis Reviews (2017) Vol. 36, Iss. 1, pp. 91-108
Open Access | Times Cited: 45
Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs’ Revolution for Immunotherapy
Giuseppina Barutello, Valeria Rolih, Maddalena Arigoni, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 3, pp. 799-799
Open Access | Times Cited: 45
Discovery of a potential biomarker for immunotherapy of melanoma: PLAC1 as an emerging target
Reza Mahmoudi, Roya Ghods, Azadeh Rakhshan, et al.
Immunopharmacology and Immunotoxicology (2020) Vol. 42, Iss. 6, pp. 604-613
Closed Access | Times Cited: 33
MultiPep: a hierarchical deep learning approach for multi-label classification of peptide bioactivities
Alexander G. B. Grønning, Tim Kacprowski, Camilla Schéele
Biology Methods and Protocols (2021)
Open Access | Times Cited: 27
Immune Checkpoint Molecules: A Review on Pathways and Immunotherapy Implications
Erfan Rezazadeh‐Gavgani, Reza Majidazar, Parisa Lotfinejad, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 4
Open Access
Host-Microbiome Interaction and Cancer: Potential Application in Precision Medicine
Alejandra Contreras, Benjamin Cocom-Chan, Georgina Hernández-Montes, et al.
Frontiers in Physiology (2016) Vol. 7
Open Access | Times Cited: 38
Regulation of the adaptation to ER stress by KLF4 facilitates melanoma cell metastasis via upregulating NUCB2 expression
Dongmei Zhang, Jingrong Lin, Yulin Chao, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top